ArticleFrontiers in endocrinology2023

Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.

Limin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.